Failure of superoxide dismutase to alter equine arachidonic acid-induced platelet aggregation, in vitro or ex vivo.

This research article reveals that in horses, superoxide dismutase (SOD), a substance known for combating inflammation by dealing with free radicals, failed to impact the aggregation of platelets prompted by arachidonic acid, both within a living body (ex vivo) and outside of one (in vitro).

Superoxide Dismutase (SOD) and its purpose

• The research sought to evaluate the impact of Superoxide Dismutase (SOD), an enzyme with anti-inflammatory capabilities and a known free radical scavenger, when administrated to horses intramuscularly (IM).
• SOD’s function in combating inflammatory disease primarily lays in its ability to counteract harmful molecules known as free radicals; these molecules are noted for their damaging effects on cells.

Analysis of SOD in the study

• The researchers were particularly interested in how the use of exogenous SOD (administered from outside) might impact the platelet prostaglandin metabolism in horses.
• To understand this relationship, they monitored the extent to which platelet aggregation (clumping together of platelets) was influenced by arachidonic acid, a fatty acid integral to inflammation and pain processes, in the blood samples of horses which were procured before SOD administration.
• These samples of platelet-rich plasma were then treated with varying concentrations of SOD and prompted to aggregate using arachidonic acid.

Key findings and implications

• The study discovered that SOD did not have any noticeable effect on arachidonic acid-induced platelet aggregation, either in the body (ex vivo) or outside of it (in vitro).
• Interestingly, however, they noted that aspirin was able to successfully stop the aggregation induced by arachidonic acid in a lab environment (in vitro).
• Consequently, the researchers propose three possibilities: first, when SOD is in a resting state, it may not have a significant impact on the free radicals derived from platelets to the extent that it could alter the arachidonic acid pathway for horse platelets. Second, horse platelets might not actually release significant amounts of free radicals. Lastly, horse platelets could be actually insensitive to the products formed from free radicals by SOD.